QA: Skye Bioscience Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001516551_2026_Skye_Bioscience_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001516551, Skye Bioscience Inc

  xvar xval
0 AssetsCurrent 27,094,147
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 898,930
3 remainder_Assets 320,556
4 LiabilitiesCurrent 8,205,459
5 LiabilitiesNoncurrent 83,999
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,729,857
9 ResearchAndDevelopmentExpense 160,534,060
10 remainder_Expenses -2,056,470
11 remainder_Revenues 0
12 remainder_NetIncome 2,847,004
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 28,313,633
1 Liabilities 8,289,458
2 Expenses 174,207,447
3 Revenues 0
4 StockholdersEquity 20,024,175
5 NetIncome -171,360,443
6 ComprehensiveNetIncome -171,360,443
7 BaseVar 106,828,771
8 EconomicCapitalRatiobeforeLimitedLiability -6.98
9 EconomicCapitalRatio 0.0287

Edgar->Model Mapping

Feature Distribution

Change over Time